WEKO3
アイテム
The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol
http://hdl.handle.net/10659/00006988
http://hdl.handle.net/10659/00006988ecd20b65-0992-48d9-8e00-77bd40b051be
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-02-21 | |||||
タイトル | ||||||
タイトル | The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | alfaxalone | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | butorphanol | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | dog | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | intramuscular anesthesia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | medetomidine | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | alfaxalone | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | butorphanol | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | dog | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | intramuscular anesthesia | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | medetomidine | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
KATO, Keiko
× KATO, Keiko× 伊丹, 貴晴× NOMOTO, Ken× ENDO, Yusuke× TAMURA, Jun× OYAMA, Norihiko× SANO, Tadashi× 山下, 和人 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | We aimed to evaluate the induction, anesthesia, and cardiorespiratory effects of intramuscular (IM) anesthetic protocol with alfaxalone following premedication with low-dose medetomidine, butorphanol, or a combination of both (medetomidine-butorphanol) in dogs. Six healthy beagles were administered 1, 2.5, or 5 mg/kg alfaxalone IM following premedication with low-dose medetomidine (5 μg/kg; MA-IM), butorphanol (0.3 mg/kg; BA-IM), or medetomidinebutorphanol (5 μg/kg and 0.3 mg/kg, respectively; MBA-IM). Each dog received 9 treatments with minimum 7-day washout period between treatments. Dogs were allowed to breath room air during anesthetic induction. We attempted endotracheal intubation after alfaxalone administration. Alfaxalone produced a dose-dependent anesthetic effect in each anesthetic protocol. Intubation was achieved in 4 out of 6 dogs that received MA-IM and BA-IM with 2.5 mg/kg alfaxalone and in all dogs that received MBA-IM with 1, 2.5, and 5 mg/kg alfaxalone. The median durations [minimum-maximum] of accepting intubation were 79 [0-89], 97 [84-120], and 117 [84-217] min, respectively. Hypotension (mean arterial blood pressure <60 mmHg) did not develop, but bradycardia (heart rate <60 beats/min) was observed in all dogs that received the MA-IM and MBA-IM protocols. Severe hypoxemia (percutaneous arterial oxygen saturation <90%) developed in 2 dogs that received MBA-IM with 5 mg/kg alfaxalone. We consider that the MA-IM and BA-IM protocols with ≥2.5 mg/kg alfaxalone and the MBA-IM protocol with 1-2.5 mg/kg alfaxalone could provide clinically useful and effective anesthesia without causing severe cardiorespiratory depression in healthy dogs. | |||||
書誌情報 |
Journal of Veterinary Medical Science 巻 83, 号 1, p. 53-61, 発行日 2021-01 |
|||||
ISBN | ||||||
識別子タイプ | ISBN | |||||
関連識別子 | 0916-7250 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1292/jvms.20-0330 | |||||
権利(URI) | ||||||
権利情報 | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
出版者 | ||||||
出版者 | 日本獣医学会 | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Article |